Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets. 

Biotechnology

Janux Therapeutics

David Campbell

Associate Director, Quality Assurance

Associate Director, Analytical Development

Megan Shannon

Tommy DiRaimondo

Director, Human Resources

Zachariah McIver

Koho Iizuka

James Pennington

Sheila Gujrathi, MD

Nick Almaguer

Lina Ma

Hans Aerni

Yogesh Bramhecha, PhD

Sara Walsh

Natalija Van Braeckel Budimir

Jerry Warren

Carolina Caffaro

Charles Winter

Brenda Van Vreeswyk

Tighe Reardon

Byron Robinson

Andy Meyer

The Finance and Accounting team at Janux Therapeutics manages the company's financial health by overseeing budgeting, financial planning and analysis, accurate financial reporting, and compliance with regulatory requirements. This team ensures effective financial operations to support the development and commercialization of Janux's innovative immunotherapies.

Finance and Accounting

Research and Development Team

Advisory Team

Leadership Team

Finance and Accounting

About

Team members

Other teams at Janux Therapeutics

Research and Development Team

Advisory Team

Leadership Team